The oversubscribed round has been backed by Takeda Ventures, UCB and Alexandria Venture Investments, and was led by Hatteras Venture Partners.

ETH Zurich and University of Zurich spinout InSphero has now raised $35m and will commercialise its organ-on-a-chip technology.

The Arizona spinout plans to develop a biopsy needle that could improve the chances of identifying precision treatments for cancer.

Tecan, Waters and Inpeco are among a group of investors that have invested $14m in robotics company Andrew Alliance.

Intuitive Surgical has led a $15m series A round for medical device manufacturer Broncus.

Nkarta has added further patents advancing an immuno-oncological approach honed by scientific founder Dario Campana.